MAPT and early-onset autosomal dominant Alzheimer disease: β isoform of GSK-3 is accountable for neurofibrillary tangle formation and Tau hyperphosphorylation, so molecules showing GSK-3β antagonistic property could be an optimistic approach for the treatment of Alzheimer’s disease (Bhat et al., 2004).